(Q39117322)

9 September 2017

Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells (English)

1 reference

9 September 2017

1 reference

1 reference

Pei-Ning Yu

1

1 reference

9 September 2017

Ming-De Yan

2

1 reference

9 September 2017

Hung-Cheng Lai

3

1 reference

9 September 2017

Rui-Lan Huang

4

1 reference

9 September 2017

Yu-Ching Chou

5

1 reference

9 September 2017

Wen-Chi Lin

6

1 reference

9 September 2017

Li-Tzu Yeh

7

1 reference

9 September 2017

Ya-Wen Lin

8

1 reference

9 September 2017

language of work or name

English

0 references

publication date

28 August 2013

1 reference

International Journal of Cancer

9 September 2017

1 reference

9 September 2017

134

1 reference

9 September 2017

3

1 reference

9 September 2017

542-551

1 reference

9 September 2017

Cancer statistics, 2013

1 reference

Ovarian cancer: strategies for overcoming resistance to chemotherapy

21 January 2018

1 reference

Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

Targeting microRNAs in cancer: rationale, strategies and challenges

21 January 2018

1 reference

microRNA involvement in human cancer

21 January 2018

1 reference

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

Role of microRNAs in drug-resistant ovarian cancer cells

21 January 2018

1 reference

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer

21 January 2018

1 reference

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

21 January 2018

1 reference

Growth inhibition of ovarian tumor-initiating cells by niclosamide.

21 January 2018

1 reference

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells

21 January 2018

1 reference

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant

21 January 2018

1 reference

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

21 January 2018

1 reference

mir-29 regulates Mcl-1 protein expression and apoptosis

21 January 2018

1 reference

MicroRNA 29b functions in acute myeloid leukemia

21 January 2018

1 reference

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

21 January 2018

1 reference

miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression

21 January 2018

1 reference

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis

21 January 2018

1 reference

Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells.

21 January 2018

1 reference

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

21 January 2018

1 reference

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).

21 January 2018

1 reference

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.

21 January 2018

1 reference

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

21 January 2018

1 reference

MicroRNA-29, a key regulator of collagen expression in systemic sclerosis

21 January 2018

1 reference

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

21 January 2018

1 reference

Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells

21 January 2018

1 reference

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins

21 January 2018

1 reference

Integrin signalling during tumour progression

21 January 2018

1 reference

Cellular processing of platinum anticancer drugs

21 January 2018

1 reference

MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance

21 January 2018

1 reference

miR221/222 in cancer: their role in tumor progression and response to therapy

21 January 2018

1 reference

miR-210: a therapeutic target in cancer

21 January 2018

1 reference

A hexanucleotide element directs microRNA nuclear import.

21 January 2018

1 reference

The role of miRNA-29 family in cancer

21 January 2018

1 reference

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

21 January 2018

1 reference

MicroRNAs in body fluids--the mix of hormones and biomarkers

21 January 2018

1 reference

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28399

1 reference

9 September 2017

1 reference